Prevalence of morbidities across the lifespan for adults with spinal muscular atrophy: a retrospective cohort study

BACKGROUND: Recently approved treatments for spinal muscular atrophy (SMA) may shift clinical care priorities to secondary complications associated with SMA-related aging. To date, there is little knowledge about the natural history of morbidities across the adult lifespan for SMA. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: G. Whitney, Daniel, E. Neil Knierbein, Erin, K. Daunter, Alecia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472659/
https://www.ncbi.nlm.nih.gov/pubmed/37653507
http://dx.doi.org/10.1186/s13023-023-02872-6

Ejemplares similares

Ejemplares similares